Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Italy’s Euticals Will Acquire Archimica
by Michael McCoy
January 17, 2011
| A version of this story appeared in
Volume 89, Issue 3
The Italian pharmaceutical chemicals company Euticals is acquiring Archimica from TowerBrook Capital Partners for an undisclosed sum. TowerBrook acquired Archimica, also a pharma chemicals firm, from Clariant in 2006. Archimica has about 550 employees at six sites in the U.S. and Europe, the main one located in Origgio, Italy. Its 2009 sales were about $170 million, up 16% from 2008, TowerBrook says. Euticals, with five plants near Milan, had sales last year of $122 million.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X